Effects of Semaglutide, PYY3-36, Antagonists of the GLP-1/NPY-Y2 Receptors, and Empagliflozin on Non-Alcoholic Fatty Liver DiseaseNiklas Haerting,Gloria Herzog,Alexander Nickel,Michael Kohlhaas,Martin Fassnacht,Christian Ziegler,Ulrich DischingerEndocrine Abstracts（2023）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
